These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26242673)

  • 21. Are the favorable outcomes of splenectomy predictable inpatients with idiopathic thrombocytopenic purpura (ITP)?
    Tsereteli Z; Smith CD; Branum GD; Galloway JR; Amerson RJ; Chakaraborty H; Hunter JG
    Surg Endosc; 2001 Dec; 15(12):1386-9. PubMed ID: 11965451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
    Pavkovic M; Trpkovska-Terzieva S; Sotirova T; Latifi A; Cevreska L; Stojanovic A
    Prilozi; 2012; 33(1):121-33. PubMed ID: 22952099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura: study of clinical and laboratory data.
    Balagué C; Vela S; Targarona EM; Gich IJ; Muñiz E; D'Ambra A; Pey A; Monllau V; Ascaso E; Martinez C; Garriga J; Trias M
    Surg Endosc; 2006 Aug; 20(8):1208-13. PubMed ID: 16865623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
    González-López TJ; Pascual C; Álvarez-Román MT; Fernández-Fuertes F; Sánchez-González B; Caparrós I; Jarque I; Mingot-Castellano ME; Hernández-Rivas JA; Martín-Salces M; Solán L; Beneit P; Jiménez R; Bernat S; Andrade MM; Cortés M; Cortti MJ; Pérez-Crespo S; Gómez-Núñez M; Olivera PE; Pérez-Rus G; Martínez-Robles V; Alonso R; Fernández-Rodríguez A; Arratibel MC; Perera M; Fernández-Miñano C; Fuertes-Palacio MA; Vázquez-Paganini JA; Gutierrez-Jomarrón I; Valcarce I; de Cabo E; Sainz A; Fisac R; Aguilar C; Paz Martínez-Badas M; Peñarrubia MJ; Calbacho M; de Cos C; González-Silva M; Coria E; Alonso A; Casaus A; Luaña A; Galán P; Fernández-Canal C; Garcia-Frade J; González-Porras JR
    Am J Hematol; 2015 Mar; 90(3):E40-3. PubMed ID: 25400215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
    Mahévas M; Gerfaud-Valentin M; Moulis G; Terriou L; Audia S; Guenin S; Le Guenno G; Salles G; Lambotte O; Limal N; Viallard JF; Cheze S; Tomowiak C; Royer B; Neel A; Debouverie O; Hot A; Durieu I; Perlat A; Cliquennois M; Deteix C; Michel M; Godeau B
    Blood; 2016 Sep; 128(12):1625-30. PubMed ID: 27354722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura.
    Duperier T; Brody F; Felsher J; Walsh RM; Rosen M; Ponsky J
    Arch Surg; 2004 Jan; 139(1):61-6; discussion 66. PubMed ID: 14718278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on responses after splenectomy for idiopathic thrombocytopenic purpura patients, Kathmandu, Nepal.
    Shrestha S; Pradhan GB; Shrestha R; Singh R
    Nepal Med Coll J; 2012 Dec; 14(4):328-30. PubMed ID: 24579545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.
    Palandri F; Polverelli N; Catani L; Sollazzo D; Romano M; Levorato M; Vianelli N
    Am J Hematol; 2014 Nov; 89(11):1047-50. PubMed ID: 25103500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reemergence of Splenectomy for ITP Second-line Treatment?
    Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
    Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
    Srinivasan S; Sabapathy K; Bharadwaj TP; Sethuraman S
    J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and Therapy of Immune thrombocytopenia].
    Matzdorff A; Wörmann B
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1076-1081. PubMed ID: 30060276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose dexamethasone for splenectomy in patients with idiopathic thrombocytopenic purpura.
    Bulvik S; Winder A; Ben-Tal O; Szold A; Eldor A
    Haemostasis; 1998; 28(5):256-9. PubMed ID: 10420075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of response to laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura.
    Kwon HC; Moon CH; Cho YR; Kim MC; Kim KH; Han JY; Lee YH; Oh SY; Kim SH; Kim JS; Kim HJ
    J Korean Med Sci; 2005 Jun; 20(3):417-20. PubMed ID: 15953862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic splenectomy is a better treatment for adult ITP than steroids--it should be used earlier in patient management. Conclusions of a ten-year follow-up study.
    Khan LR; Nixon SJ
    Surgeon; 2007 Feb; 5(1):3-4, 6-8. PubMed ID: 17313122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.
    Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O
    Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series.
    Kowalczyk M; Rubinstein PG; Aboulafia DM
    J Int Assoc Provid AIDS Care; 2015; 14(3):211-6. PubMed ID: 25504472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
    Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN
    Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.